Titan Pharmaceuticals Inc (NAS:TTNP)
$ 3.465 0.225 (6.94%) Market Cap: 3.17 Mil Enterprise Value: -2.96 Mil PE Ratio: 0 PB Ratio: 0.79 GF Score: 38/100

Q3 2019 Titan Pharmaceuticals Inc Earnings Call Transcript

Nov 14, 2019 / 09:30PM GMT
Release Date Price: $112.2 (+12.04%)
Operator

Thank you for holding, and welcome to the Titan Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being taped at the company's request and will be archived on the company's website starting later today.

At this time, I would like to turn the call over to Sunil Bhonsle, President and CEO of Titan Pharmaceuticals. Please go ahead.

Sunil Bhonsle
Titan Pharmaceuticals, Inc. - President, CEO, Principal Financial Officer & Director

Thank you, Allison, and thank you all for joining us. Welcome to the Titan Pharmaceuticals to review the financial and operational results for the third quarter ended September 30, 2019, and also provide an update on our business.

But before we begin, I wanted to inform you that we filed our quarterly report on Form 10-Q with the SEC. And the press release issued earlier today provides a summary of the results and can be found also on our website at titanpharm.com.

Joining me on the call today from Titan are Dr. Marc Rubin, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot